Pharmaceutical Excipient Market by Type (Inorganic, Organic), Formulation (Oral Formulations, Parenteral Formulations, Topical Formulations), Function - Global Forecast 2024-2030
Pharmaceutical Excipient Market by Type (Inorganic, Organic), Formulation (Oral Formulations, Parenteral Formulations, Topical Formulations), Function - Global Forecast 2024-2030
The Pharmaceutical Excipient Market size was estimated at USD 8.62 billion in 2023 and expected to reach USD 9.22 billion in 2024, at a CAGR 7.62% to reach USD 14.42 billion by 2030.
Pharmaceutical excipients are added to pharmaceutical products for various purposes, including improving the manufacturing process, enhancing stability, ensuring the bioavailability of the drug, and facilitating the administration and dosing of the final product. Excipients are essentially inactive components that support the overall formulation and delivery of the active ingredient. The market for pharmaceutical excipients is primarily driven by the increasing demand for pharmaceutical products due to the rising global population and chronic diseases. Technological advancements in drug formulation and developing novel excipients also contribute to market growth. Furthermore, the expansion of the generic pharmaceuticals sector and the trend toward self-medication for minor health issues provide a strong impetus for the excipient market. However, stringent regulatory requirements leading to lengthy approval processes can impede the introduction of new excipients, and the high cost associated with developing and producing advanced excipients hamper its market growth. The shift toward multifunctional and co-processed excipients and ongoing advancements and research activities for developing biobased excipients opens significant opportunities for market players, offering benefits such as improved product performance and production efficiency.
Regional Insights
The Americas region has a significant landscape in the pharmaceutical excipient market as countries exhibit a high demand for excipients, directed by stringent regulatory environments, advanced healthcare systems, and strong intellectual property frameworks. Having a significant landscape in pharmaceutical innovation, the countries in the region strongly focus on advanced and novel excipients for drug formulations. The EMEA region, which encompasses Europe, the Middle East, and Africa, shows diverse market characteristics. The stringent regulatory environment in the European Union drives the demand for compliant and high-quality excipients, whereas markets in the Middle East and Africa are burgeoning, with increasing investment in pharmaceutical manufacturing infrastructure and regulation. The EU market demonstrates a high need for cutting-edge pharmaceutical excipients that cater to complex drugs and sophisticated drug delivery systems. Moreover, the EU's investment in biopharmaceuticals and biosimilars is complemented by the growing demand for novel excipients in these areas. Countries in the Asia-Pacific region are key players in the pharmaceutical excipient sector experiencing substantial growth due to a large patient pool, increasing healthcare expenditures, and supportive government initiatives. The region focuses on innovating high-functional excipients with ongoing research and development, reducing its historical reliance on imports.
Market Insights
Market Dynamics
The market dynamics represent an ever-changing landscape of the Pharmaceutical Excipient Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
Market Drivers
Rising incidence of cancer and other chronic and infectious diseases worldwide
Growth of the pharmaceuticals industry coupled with significant demand for generics & orphan drugs
Significant emphasis on the production of multifunctional excipients
Market Restraints
High cost associated with the production of advanced excipient
Market Opportunities
Technological advancements in nanotechnology for excipients
Ongoing research and development of excipients with numerous properties (Biobased)
Market Challenges
Increasing regulatory stringency and issues regarding the compatibility of excipients
Market Segmentation Analysis
Type: Potential demand and utilization of organic excipients
Formulation: Significant demand for oral formulations owing to its convenient drug delivery
Function: Coating agents provide physical and chemical protection for the drug
Market Disruption Analysis
Porter’s Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Pharmaceutical Excipient Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Pharmaceutical Excipient Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Roquette Introduces New Advancement in Moisture Protection
Roquette Pharma launched innovative excipient solutions specifically designed to enhance moisture protection. These advanced formulations cater to the growing need for high-performance excipients capable of extending the shelf-life and stability of moisture-sensitive drugs, responding to a critical challenge within the sector. By leveraging cutting-edge technology, Roquette Pharma is poised to set a new standard in excipient functionality, further solidifying its position in the pharmaceutical excipient market.
Clariant Launches New Range Of Excipients To Improve Stability And Solubility of Apis at CPHI Barcelona
Clariant announced the introduction of an innovative portfolio of pharmaceutical experiments, unveiled at CPHI Barcelona. These cutting-edge products are formulated to enhance the stability and solubility of active pharmaceutical ingredients (APIs). The new range addresses critical formulation challenges faced by pharmaceutical companies, enabling easier administration and improved patient compliance.
BASF, IFF Partner on Virtual Pharma Assistant Platform ZoomLab
BASF and International Flavors & Fragrances (IFF) have partnered to create an innovative virtual pharma assistant platform designed to enhance the functionality and application of pharmaceutical excipients. This digital tool aims to streamline the formulation process by providing real-time, data-driven insights and guidance on selecting and combining excipients.
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Pharmaceutical Excipient Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Pharmaceutical Excipient Market, highlighting leading vendors and their innovative profiles. These include ABITEC Corporation, Aceto Corp., Archer Daniels Midland Company, ARMOR PROTEINES S.A.S., Asahi Kasei Corporation, Ashland Inc., BASF SE, BIOGRUND GmbH, Chemische Fabrik Budenheim KG, Clariant AG, Colorcon Inc., Corel Pharma Chem Private Limited, Croda International Plc, Darling Ingredients, Inc., DFE Pharma GmbH & Co KG, DuPont de Nemours, Inc., Evonik Industries AG, Fuji Chemical Industries Co., Ltd., GATTEFOSSE SAS, Innophos Holdings, Inc., International Flavors & Fragrances Inc., JRS PHARMA GmbH + Co. KG, Kerry Group P.L.C., Lipoid GmbH, Lubrizol Corporation, L’AIR LIQUIDE S.A., Mallinckrodt plc, MEGGLE GmbH & Co. KG, Merck KGaA, Nagase & Co., Ltd., Nipon Soda Co., Ltd., NOF Corporation, Omya International AG, Peter Greven GmbH & Co. KG, R.T. Vanderbilt Holding Company, Inc., Resonac Holdings Corporation, Roquette Frères S.A., Shin-Etsu Chemical Co., Ltd., Solvay S.A., SPI Pharma, Inc., and Thermo Fisher Scientific Inc..
Market Segmentation & Coverage
This research report categorizes the Pharmaceutical Excipient Market to forecast the revenues and analyze trends in each of the following sub-markets:
Type
Inorganic
Calcium Carbonate
Calcium Phosphate
Calcium Sulfate
Halites
Metal Oxides
Organic
Carbohydrates
Cellulose
Starch
Sugars
Oleochemicals
Fatty Alcohols
Glycerin
Mineral Stearates
Petrochemicals
Acrylic Polymers
Glycols
Mineral Hydrocarbons
Povidones
Proteins
Formulation
Oral Formulations
Hard Gelatin Capsules
Liquid Formulations
Soft Gelatin Capsules
Tablets
Parenteral Formulations
Topical Formulations
Function
Binders
Coating Agents
Colorants
Disintegrants
Emulsifying Agents
Fillers & Diluents
Flavoring Agents & Sweeteners
Lubricants & Glidants
Preservatives
Suspending & Viscosity Agents
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
Please Note: PDF & Excel + Online Access - 1 Year
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidence of cancer and other chronic and infectious diseases worldwide
5.1.1.2. Growth of the pharmaceuticals industry coupled with significant demand for generics & orphan drugs
5.1.1.3. Significant emphasis on the production of multifunctional excipients
5.1.2. Restraints
5.1.2.1. High cost associated with the production of advanced excipient
5.1.3. Opportunities
5.1.3.1. Technological advancements in nanotechnology for excipients
5.1.3.2. Ongoing research and development of excipients with numerous properties (Biobased)
5.1.4. Challenges
5.1.4.1. Increasing regulatory stringency and issues regarding the compatibility of excipients
5.2. Market Segmentation Analysis
5.2.1. Type: Potential demand and utilization of organic excipients
5.2.2. Formulation: Significant demand for oral formulations owing to its convenient drug delivery
5.2.3. Function: Coating agents provide physical and chemical protection for the drug
5.3. Market Trend Analysis
5.3.1. Substantial investments to increase drug manufacturing to propel the demand for pharmaceutical excipient in the Americas
5.3.2. Supportive government initiatives to encourage exports of pharmaceutical products in the Asia-Pacific
5.3.3. Flourishing pharmaceutical sector, coupled with a growing focus on localizing drug manufacturing in the EMEA region
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework Analysis
6. Pharmaceutical Excipient Market, by Type
6.1. Introduction
6.2. Inorganic
6.3. Organic
7. Pharmaceutical Excipient Market, by Formulation
7.1. Introduction
7.2. Oral Formulations
7.3. Parenteral Formulations
7.4. Topical Formulations
8. Pharmaceutical Excipient Market, by Function
8.1. Introduction
8.2. Binders
8.3. Coating Agents
8.4. Colorants
8.5. Disintegrants
8.6. Emulsifying Agents
8.7. Fillers & Diluents
8.8. Flavoring Agents & Sweeteners
8.9. Lubricants & Glidants
8.10. Preservatives
8.11. Suspending & Viscosity Agents
9. Americas Pharmaceutical Excipient Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Pharmaceutical Excipient Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Pharmaceutical Excipient Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Roquette Introduces New Advancement in Moisture Protection
12.3.2. Clariant Launches New Range Of Excipients To Improve Stability And Solubility of Apis at CPHI Barcelona
12.3.3. BASF, IFF Partner on Virtual Pharma Assistant Platform ZoomLab
12.3.4. Lubrizol Licenses Award-Winning Apisolex Excipient to Welton Pharma to Develop a Novel Cancer Therapeutic
12.3.5. Ingredion Announces Strategic Investments Expanding Into High-Value Pharmaceutical Ingredients
12.3.6. DFE Pharma Expands its Inhalation Portfolio with the Launch of Lactohale 400
12.3.7. Evonik invests USD 220 million in partnership with the U.S. Government to build a new lipid production facility for mRNA-based therapies in the U.S.
12.3.8. Lubrizol Launches Apisolex Technology
12.3.9. Univar Solutions Expands Pharmaceutical Products Portfolio Through New Distribution Agreement with Ashland
12.3.10. Azelis Strengthens Its Pharmaceutical Presence in India By Expanding its Partnership With Roquette
12.3.11. Roquette Expands Global Reach of Plant-Based Excipients Portfolio with Complete Acquisition of Crest Cellulose